Vimarsana
Biggest News Aggregation in the World

Page 4 - Instruments Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Instruments Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Instruments Segment Today - Breaking & Trending Today

Global Acoustic Emission Testing Market to Reach $407.1 Million by 2026 - Vimarsana News

Global Acoustic Emission Testing Market to Reach $407.1 Million by 2026

/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...

Orthodontic Instruments Sales Market Report-By Company Analysis: Ormco Corporation, American Orthodontics – KSU - Vimarsana News

Orthodontic Instruments Sales Market Report-By Company Analysis: Ormco Corporation, American Orthodontics – KSU

1.4.1 Global Orthodontic Instruments Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Orthodontic Instruments Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Orthodontic Instruments Price Trends (2016-2027) 2 Orthodontic Instruments Estimates and Forecasts by Region 2.1 Global Orthodontic Instruments Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Orthodontic Instruments Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Orthodontic Instruments Sales Market Share by Region (2016-2021) 2.2.2 Global Orthodontic Instruments Revenue Market Share by Region ...

Thermo Fisher Scientific Reports First Quarter 2021 Results - Vimarsana News

Thermo Fisher Scientific Reports First Quarter 2021 Results

Thermo Fisher Scientific Reports First Quarter 2021 Results News provided by Share this article Share this article WALTHAM, Mass., April 29, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021. First Quarter 2021 Highlights First quarter GAAP diluted earnings per share (EPS) increased 198% to $5.88. First quarter adjusted EPS increased 145% to $7.21. Continued significant role in enabling the COVID-19 response, helping to scale vaccine production and supporting t...